Status: current, Defined. Date: 30-Jun 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4132201000168113 | Stalevo 50/12.5/200 (carbidopa 12.5 mg + entacapone 200 mg + levodopa 50 mg) tablet, 10 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4132211000168111 | Stalevo 50/12.5/200 tablet, 10, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Stalevo 50/12.5/200 tablet, 10, bottle | Is a | Stalevo 50/12.5/200 tablet, 10 | true | Inferred relationship | Some | ||
| Stalevo 50/12.5/200 tablet, 10, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Stalevo 50/12.5/200 tablet, 10, bottle | has TPUU | Stalevo 50/12.5/200 tablet | true | Inferred relationship | Some | 1 | |
| Stalevo 50/12.5/200 tablet, 10, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Stalevo 50/12.5/200 tablet, 10, bottle | has TP | Stalevo 50/12.5/200 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR